BridgeBio Pharma earnings beat by $0.14, revenue topped estimates

Resumen del corpus

BridgeBio Pharma reported third-quarter earnings where the Earnings Per Share (EPS) was $0.14 better than the analyst estimate of -$0.56. Furthermore, the revenue for the quarter reached $353.17 million, surpassing the consensus estimate of $281.65 million. The company's stock price closed at $70.73 following these results, with the financial health score rated as 'good performance'.